DJIA 17,084.49 33.74 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo

Geron Corp (NASDAQ: GERN)

3.07 0.10 (3.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $3.07 3.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.97
Previous Close $2.97
Daily Range $2.95 - $3.11
52-Week Range $1.76 - $4.67
Market Cap $485.5M
P/E Ratio -12.38
Dividend (Yield) $0.00 (0.0%)
Volume 1,813,093
Average Daily Volume 3,516,040
Current FY EPS -$0.05




Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary

This Small-Cap Biotech Could Wind Up Devouring a Much Larger Foe's Revenue Stream

Representing a true David versus Goliath battle in the biotech space, this $500 million cancer drug developer could soon dethrone a $21 billion giant.

Should Geron Corporation (GERN) Be On Your Radar Now?

Can Geron (GERN) Run Higher on Strong Earnings Estimate Revisions?

One Way To Bet On The American Society Of Hematology's Meeting Next Month

Today's Perilous Reversal Stock: Geron (GERN)

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

Strong On High Relative Volume: Geron (GERN)

Geron: Calculating The Potential Value Gap

Morning Market Gainers

Health Care Sector Update for 09/16/2015: BMY, AGN, GERN

Benzinga's Top #PreMarket Gainers

See More GERN News...

GERN's Top Competitors

GERN $3.07 (3.37%)
Current stock: GERN
AMGN $149.59 (-0.21%)
Current stock: AMGN
GILD $100.65 (-0.16%)
Current stock: GILD
BIIB $269.16 (-3.83%)
Current stock: BIIB